RPG Life Sciences ↗

1993 📍 Mumbai, Maharashtra, India Active NSE RPGLIFE CIN L24232MH2007PLC169354 Pharmaceuticals & Healthcare

Search companies

Key Metrics of RPG Life Sciences

Revenue₹708 Cr▲ 8.3% YoYFY 2025-26

EBITDA₹177 Cr▼ 30.7% YoY

Net profit₹115 Cr▼ 37.1% YoY

Net worth₹605 Cr▲ 14.1% YoY

Competitors10identified

About RPG Life Sciences

Sectors

Pharmaceuticals & HealthcareFormulations & Contract Manufacturing

Company details

Website: rpglifesciences.com
Founded: 1993
Registered office: Rpg House, 463, Dr. Annie Besant Road,, Worli, Mumbai, Mumbai, In-mh, 400030
Listed: NSE: RPGLIFE · ₹2,619.60

Operational Areas of RPG Life Sciences

Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing

Company summary

Entity details

CINL24232MH2007PLC169354

LEI code335800O9C9JKWKXY5Y66

State codeMH

PIN code400030

Current legal nameRPG LIFE SCIENCES

Classification—

Listing statusListed

Registration no.169354

Company age33 years, 9 months

PAN—

CountryIndia

CityMumbai

StateMaharashtra

Current statusActive

Date of incorporation01 Jan 1993

Registrar of companies—

Authorised capital—

Paid-up capital—

Employee count—

Compliance

Last AGM date—

Last balance sheet—

Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code24232

Description of main activityManufacture of chemicals and chemical products (incl. pharmaceuticals)

Description of business activityManufacture of chemicals and chemical products (incl. pharmaceuticals)

SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed

AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 6 days left

MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 36 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Credit ratings

CARE · 03 Mar 2014 — Assigned

Change in last 12 months—

Change since first rating on record—since Aug 2010

Rating actions20 up · 0 down

Rating actions

Date	Agency	Action	Long term	Short term	Outlook	Rated amount	Rationale
03 Mar 2014	CARE	Assigned	—	—	—	—	View
27 Aug 2010	CARE	Other	—	—	—	—	View

Borrowings & rated debt

Rated borrowing limits (latest)—

Limits raised0 times0 new facilities rated

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—

Indicative short-term—

Score—

LiquidityStrong

DirectionStable

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

Default	No default on record
Issuer cooperation	Cooperating
Credit enhancement	None – standalone rating
Information on file	56% · missing: Capex / investment plans, Lender details, Auditor details, Recent rating review (last 15 months)

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report ⬇ Excel

Can it borrow more?Further bank funding difficult Next rating action stable or better: 35% (Downgrade likely) · scorecard until enough rating history is collected

Rated limits—

Not yet allocated—

Extra debt within 2.5× EBITDA—

Interest coverage—

Limit utilisation—

Open bank charges0 · —

Credit outlook model: 35% chance the next rating action is stable or better

Rated limits by facility

Timeline

03 Mar 2014 CARE assigned: — CARE rationale

27 Aug 2010 CARE other: — CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeRPG HOUSE, 463, DR. ANNIE BESANT ROAD,, WORLI, MUMBAI, MUMBAI, IN-MH, 400030

GSTIN—

Email—

Websitehttp://www.rpglifesciences.com

Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of RPG Life Sciences

Competitors10identified

Locations3most in India

Top competitors by location

Company	Description	Domain	Founded	Location
Dr. Reddy's Laboratories	Part of Dr. Reddy's Laboratories.	drreddys.com	1984	India
Aurobindo Pharma	Part of Aurobindo Pharma.	aurobindo.com	1986	Hyderabad, India
Cipla	Part of Cipla.	cipla.com	1935	Mumbai, India
Lupin Ltd.	Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare	lupin.com	1968	India
Glenmark Pharmaceuticals	Part of Glenmark Pharmaceuticals.	glenmarkpharma.com	1977	Mumbai, India
Biocon	Part of Biocon.	biocon.com	1978	Bangalore, India
ALKEM LABORATORIES LIMITED	Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare	alkemlabs.com	1973	Mumbai, Maharashtra, India
Torrent Pharmaceuticals	Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare	torrentpharma.com	1959	Ahmedabad, India
ASTER DM QUALITY CARE LIMITED	Discovered Companies · Other Industries	—	—	Hyderabad, Telangana, India
Thomas Cook India	Part of Thomas Cook Group.	thomascook.in	1978	Mumbai, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.